These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 37204221)

  • 1. Mucoadhesive Emulsion Microgels for Intravesical Drug Delivery: Preparation, Retention at Urothelium, and Biodistribution Study.
    Saveleva MS; Lobanov ME; Gusliakova OI; Plastun VO; Prikhozhdenko ES; Sindeeva OA; Gorin DA; Mayorova OA
    ACS Appl Mater Interfaces; 2023 May; 15(21):25354-25368. PubMed ID: 37204221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of intravenous and intravesical administration of chloro-aluminum sulfonated phthalocyanine for photodynamic treatment in a rat bladder cancer model.
    Bachor R; Flotte TJ; Scholz M; Dretler S; Hasan T
    J Urol; 1992 May; 147(5):1404-10. PubMed ID: 1569696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of different carbon nanotubes for the development of a mucoadhesive drug delivery system for intravesical treatment of bladder cancer.
    Rieger C; Kunhardt D; Kaufmann A; Schendel D; Huebner D; Erdmann K; Propping S; Wirth MP; Schwenzer B; Fuessel S; Hampel S
    Int J Pharm; 2015 Feb; 479(2):357-63. PubMed ID: 25595385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucoadhesive polyacrylamide nanogel as a potential hydrophobic drug carrier for intravesical bladder cancer therapy.
    Lu S; Neoh KG; Kang ET; Mahendran R; Chiong E
    Eur J Pharm Sci; 2015 May; 72():57-68. PubMed ID: 25772330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucoadhesive maleimide-functionalised liposomes for drug delivery to urinary bladder.
    Kaldybekov DB; Tonglairoum P; Opanasopit P; Khutoryanskiy VV
    Eur J Pharm Sci; 2018 Jan; 111():83-90. PubMed ID: 28958893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urothelium-adherent, ion-triggered liposome-in-gel system as a platform for intravesical drug delivery.
    GuhaSarkar S; More P; Banerjee R
    J Control Release; 2017 Jan; 245():147-156. PubMed ID: 27913307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug delivery system based on dendritic nanoparticles for enhancement of intravesical instillation.
    Qiu X; Cao K; Lin T; Chen W; Yuan A; Wu J; Hu Y; Guo H
    Int J Nanomedicine; 2017; 12():7365-7374. PubMed ID: 29066888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microscopic quantification of hypercin fluorescence in an orthotopic rat bladder tumor model after intravesical instillation.
    Kamuhabwa AA; Roskams T; Baert L; De Witte PA
    Int J Oncol; 2003 Apr; 22(4):933-7. PubMed ID: 12632090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravesical drug delivery: Challenges, current status, opportunities and novel strategies.
    GuhaSarkar S; Banerjee R
    J Control Release; 2010 Dec; 148(2):147-59. PubMed ID: 20831887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic model of drug distribution in the urinary bladder wall following intravesical instillation.
    Grabnar I; Bogataj M; Belic A; Logar V; Karba R; Mrhar A
    Int J Pharm; 2006 Sep; 322(1-2):52-9. PubMed ID: 16806751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained intravesical drug delivery using thermosensitive hydrogel.
    Tyagi P; Li Z; Chancellor M; De Groat WC; Yoshimura N; Huang L
    Pharm Res; 2004 May; 21(5):832-7. PubMed ID: 15180342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and Evaluation of Boronated Chitosan as a Mucoadhesive Polymer for Intravesical Drug Delivery.
    Kolawole OM; Lau WM; Khutoryanskiy VV
    J Pharm Sci; 2019 Sep; 108(9):3046-3053. PubMed ID: 31091425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo evaluation of mucoadhesive nanoparticulate docetaxel for intravesical treatment of non-muscle-invasive bladder cancer.
    Mugabe C; Matsui Y; So AI; Gleave ME; Baker JH; Minchinton AI; Manisali I; Liggins R; Brooks DE; Burt HM
    Clin Cancer Res; 2011 May; 17(9):2788-98. PubMed ID: 21357680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bladder tissue pharmacokinetics of intravesical taxol.
    Song D; Wientjes MG; Au JL
    Cancer Chemother Pharmacol; 1997; 40(4):285-92. PubMed ID: 9225946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravesical delivery of 5-aminolevulinic acid from water-in-oil nano/submicron-emulsion systems.
    Fang JY; Wu PC; Fang CL; Chen CH
    J Pharm Sci; 2010 May; 99(5):2375-85. PubMed ID: 19921749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigating detrusor muscle concentrations of oxybutynin after intravesical delivery in an ex vivo porcine model.
    Williams NA; Lee KM; Allender CJ; Bowen JL; Gumbleton M; Harrah T; Raja A; Joshi HB
    J Pharm Sci; 2015 Jul; 104(7):2233-40. PubMed ID: 25989054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Retention Microbubbles with Three-Layer Structure for Floating Intravesical Instillation Delivery.
    Deng Q; Xie J; Kong S; Tang T; Zhou J
    Small; 2023 Apr; 19(14):e2205630. PubMed ID: 36634975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-delivery of peptide-modified cisplatin and doxorubicin via mucoadhesive nanocapsules for potential synergistic intravesical chemotherapy of non-muscle-invasive bladder cancer.
    Lu S; Xu L; Kang ET; Mahendran R; Chiong E; Neoh KG
    Eur J Pharm Sci; 2016 Mar; 84():103-15. PubMed ID: 26780592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro evaluation of intravesical mucoadhesive self-emulsifying drug delivery systems.
    Lupo N; Jalil A; Nazir I; Gust R; Bernkop-Schnürch A
    Int J Pharm; 2019 Jun; 564():180-187. PubMed ID: 30981873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Permeation enhancer-containing water-in-oil nanoemulsions as carriers for intravesical cisplatin delivery.
    Hwang TL; Fang CL; Chen CH; Fang JY
    Pharm Res; 2009 Oct; 26(10):2314-23. PubMed ID: 19653070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.